Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Becton Dickinson and Co BDX

Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, and others. The Company's BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a wide range of settings. The BD Medical segment consists of various business units, including medication delivery solutions, medication management solutions, and pharmaceutical systems. The Company's BD Life Sciences segment provides products for the collection and transport of diagnostics specimens, and instruments and reagent systems to detect a broad range of infectious diseases, healthcare-associated infections and cancers. The Company's BD Interventional segment provides vascular, urology, oncology and surgical specialty products.


NYSE:BDX - Post by User

Post by zayaroy18on Jul 01, 2022 5:40am
145 Views
Post# 34795792

Enteric Disease Testing Market Size, Share, Trends Report

Enteric Disease Testing Market Size, Share, Trends Report

According to the latest IMARC Group report, titled “Enteric Disease Testing Market : Global Industry Trends, Size, Growth, Opportunity and Forecast 2021-2026”, The global enteric disease testing market size reached US$ 3.87 Billion in 2020. Looking forward, the market expects to exhibit stable growth during 2021-2026.

Report Metric

Historical: 2015-2020

Base Year: 2020

Forecast Year: 2021-2026

Enteric disease testing assists in identifying communicable diseases caused by different microorganisms, such as viruses, parasites, and bacteria,which enter the body through the mouth. Nowadays, various testing techniques are available that can be used as per the disease type and individual patient.
Global Enteric Disease Testing Market Trends:

The increasing prevalence of bacterial disorders, such as intestine infections, polio, typhoid, E.coli, and rotavirus, among the masses represents one of the key factors bolstering the market growth. In addition to this, rising cases of food and water-borne diseases worldwide are propelling the market growth. Apart from this, key players operating in the industry are introducing rapid diagnostic tests kits for quick testing, which is enabling them to expand the existing market share. Furthermore, the improving healthcare infrastructure, technological advancements, and expanding medical tourism are some of the other factors projected to create a positive outlook for the market in the coming years.

 

Request Free Sample Report: https://www.imarcgroup.com/enteric-disease-testing-market/requestsample

As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

Global Enteric Disease Testing 2021-2026 Analysis and Segmentation:

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

Abbott Laboratories, BD (Becton, Dickinson and Company), Bio-Rad Laboratories Inc., Biomerica Inc., Biomrieux SA, Cepheid Inc. (Danaher Corporation), Coris BioConcept, DiaSorin, Meridian Bioscience Inc. and Quest Diagnostics.

 

The report has segmented the market on the basis on region, product type, technique, disease type and end-user.

Breakup by Product Type:

  • Reagents and Consumables
  • Equipment

Breakup by Technique:

  • Molecular Diagnostics
  • Immunodiagnostics

Breakup by Disease Type:

  • Bacterial Enteric Disease
  • Viral Enteric Disease
  • Parasitic Enteric Disease

Breakup by End User:

  • Hospital Diagnostic Laboratories
  • Independent Diagnostic Laboratories
  • Academic and Research Institutes
  • Others

Breakup by Region:

  • North America: (United States, Canada)
  • Asia Pacific: (China, Japan,India, South Korea, Australia, Indonesia, Others)
  • Europe: (Germany, France,United Kingdom, Italy, Spain, Russia, Others)
  • Latin America: (Brazil, Mexico, Others)
  • Middle East and Africa
 

If you want latest primary and secondary data (2021-2026) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.

Key highlights of the report:

  • Market Performance (2015-2020)
  • Market Outlook (2021- 2026)
  • Porter’s Five Forces Analysis
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Value Chain
  • Comprehensive Mapping of the Competitive Landscape

If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/enteric-disease-testing-market

 

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:
Email: sales@imarcgroup.com
Toll Free Number: USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 30 N Gould St, Ste R
Sheridan, WY 82801, USA
Website: https://www.imarcgroup.com/
Follow us on twitter: @imarcglobal
Linkedin: https://www.linkedin.com/company/imarc-group


<< Previous
Bullboard Posts
Next >>